Our toxicology program improves the safety and quality of patient lives, while protecting physicians and increasing their office efficiency.
Using pharmacogenetics, physicians can customize treatment plans that minimize Adverse Drug Reactions (ADRs), side effects or hazards.
Our Hereditary Panels analyze the most frequent syndromes that present predisposition to cancer, which may lead to the development of tumors such as: breast and ovarian, colorectal, prostate, lung, as well as genes that are associated with an increased susceptibility to the development of neoplasia.
The Prosigna® Breast Cancer Prognostic Gene Signature Assay is a Medicare covered diagnostic exam, performed in vitro, using FFPE breast tumor tissue from patients previously diagnosed with invasive breast carcinoma.
Verifi® by Selecta Labs is a simple blood test that screens for the most common chromosomal abnormalities that can affect your baby’s future health. A sample can be drawn in your doctor’s office as early as the 10th week of pregnancy, and it may help you avoid more invasive procedures, such as amniocentesis or chorionic villus sampling (CVS), which are not without risks to you and your baby.
We offer the latest in laboratory testing so that you can provide the best in care for your patients. From routine chemistry and hematology testing to the most advanced microbiology, PCR and molecular-based tests, we offer the options you need to get fast and accurate clinical data so that you can quickly treat your patients and get them well.
